The global single-use medical device reprocessing market has been estimated at USD 1625.9 million in 2017. The market is expected to register a CAGR of 14% during the forecast period, 2018 to 2023. North America accounted for the largest market, while Europe is the next to North America in the single-use medical device reprocessing.
Cost Savings through Reprocessing Single-Use Devices
In 2002, the Food and Drug Administration established statutory requirements for reprocessing of single-use devices (SUD) by approved reprocessors to save costs and reduce medical waste. Reprocessed single-use medical devices are as safe and effective as original medical equipment, but with greater affordability. The use of re-processed SUDs also results in reduction of costs associated with special handling and waste management of devices. Healthcare facilities not only save 50% for every reprocessed SUD they purchase and spend less on medical disposal, but they also save money when original equipment manufacturers (OEMs) lower their prices to compete with third-party re-processors, thus lowering the overall cost of healthcare. Along with the cost reduction it also results in environmental sustainability.
Quality of Reprocessed Single Use Medical Devices (SUD’S)
In 2008 United States GOA published a report on Reprocessed single-use medical device and looked into each complaint made on the use of single use medical device (SUD). They found that of the over 320,000 adverse events filed with FDA between 2000 and 2006, only 65 adverse events actually involved, or were suspected to involve a reprocessed SUD and that the reprocessed SUD was one of several possible causal factors in adverse events. In reviewing these type of reports, FDA found that the types of adverse events reported to be associated with the use of reprocessed SUDs were the same types of events that were reported for new devices. These report has established the safety, but have not been able to clear the preconceived notion regarding the quality of reprocessed SUDs. Quality of healthcare facilities, quality of device material, and regulations of single use medical devices are the primary concerns of every payer and these are limiting the market’s growth.
North America to Dominate the Market Growth
North America accounted for the largest market, accounting for around 42% of the global market share and is expected to witness a high CAGR of 19% over the forecast period. Along with the North America region, Europe is the next leading region growing at a CAGR of 6.11% in the global molecular diagnostics market. Asia-Pacific is growing for single-use medical device reprocessing market and the reuse of Single-Use Devices in much of Asia is common, particularly for injection needles. For the most part, there are no national regulations governing reuse of SUDs and, thus, third-party reprocessors do not offer their services in Asia.
Key Developments in the Market
• January 2017: Ethicon Endo-Surgery, Inc. has acquired the Megadyne Medical Products, Inc.
• August 2017: Medline Industries purchased the Aplicare skin antisepsis business from the Clorox Company.
Major Key Players: STRYKER SUSTAINABILITY SOLUTIONS, STERILMED INC. (ACQUIRED BY ETHICON-ENDO SURGERY INC., PART OF THE JOHNSON & JOHNSON FAMILY OF COMPANIES), MEDLINE RENEWAL, VANGUARD AG, HYGIA HEALTH SERVICES INC., SURETEK MEDICAL, RENU MEDICAL, NESCIENTIFIC INC.
Reasons to Purchase this Report
• Current and future single-use medical device reprocessing market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER'S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 HEALTHCARE FACILITIES ACHIEVE SIGNIFICANT COST SAVINGS THROUGH REPROCESSING SINGLE-USE DEVICES
6.1.2 REPROCESSING SINGLE-USE DEVICES RESULTS IN ENVIRONMENTAL SUSTAINABILITY
6.2 MARKET RESTRAINTS
6.2.1 POTENTIAL OF MATERIAL ALTERATION AND CROSS INFECTION WITH REPROCESSED DEVICE
6.2.2 PRECONCEIVED NOTION REGARDING THE QUALITY OF REPROCESSED SINGLE USE MEDICAL DEVICES (SUD’s)
6.2.3 VERY LITTLE TO NO REGULATION OF SINGLE USE DEVICE (SUD) REPROCESSING IN EMERGING MARKETS
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 SEGMENTATION-BY DEVICE TYPE
7.1.1 CLASS I DEVICES
184.108.40.206 SEQUENTIAL COMPRESSION SLEEVES
220.127.116.11 TOURNIQUET CUFFS
18.104.22.168 PULSE OXIMETER SENSORS
7.1.2 CLASS II DEVICE
22.214.171.124 CAUTERY ELECTRODES
126.96.36.199 LAPAROSCOPIC GRASPERS
188.8.131.52 ORTHOPEDIC BLADES
184.108.40.206 DRILL BITS
220.127.116.11 EXTERNAL FIXATION CLAMPS
18.104.22.168 ELECTROPHYSIOLOGICAL CARDIAC CATHETERS
7.2 SEGMENTATION-BY GEOGRAPHY
7.2.1 NORTH AMERICA
22.214.171.124 UNITED STATES
126.96.36.199 UNITED KINGDOM
188.8.131.52 REST OF EUROPE
184.108.40.206 AUSTRALIA & NEW ZEALAND
220.127.116.11 SOUTH KOREA
18.104.22.168 REST OF ASIA-PACIFIC
7.2.4 MIDDLE EAST & AFRICA
22.214.171.124 SOUTH AFRICA
126.96.36.199 REST OF THE MIDDLE EAST & AFRICA
7.2.5 SOUTH AMERICA
188.8.131.52 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. KEY PLAYERS
9.1 STRYKER SUSTAINABILITY SOLUTIONS
9.2 STERILMED INC
9.3 MEDLINE RENEWAL
9.4 VANGUARD AG
9.5 HYGIA HEALTH SERVICES, INC
9.6 SURETEK MEDICAL
9.7 RENU MEDICAL
9.8 NESCIENTIFIC INC
10. FUTURE OF THE MARKET